The Philip Morris company has made organizational changes in an attempt to further its vision for a smoke free future.
New roles in the company include chief consumer officer, chief life sciences officer, chief product officer and chief new ventures officer. All positions will report to Andre Calantzopoulous, CEO of Philip Morris International.
“Since the launch of our smoke-free product, IQOS, in 2014, we have made enormous progress both in terms of organizational capabilities, know-how and in our business results. With IQOS commercialized in 47 markets today, we are extremely proud of what has been achieved to date, including two recent milestones: realizing 10 million users and the U.S. FDA authorization to commercialize this smoke-free alternative in the U.S.,” said Calantzopoulos. “To accelerate, we must further enhance our ability to stay at the forefront of technology, science and consumer centricity.”
Mirek Zielinski will assume the role of chief new ventures officer. He currently holds the position of president of science and innovation. The other three positions will be new hires.
“It is both humbling and reassuring that we are able to attract senior executives of such deep experience, credibility and expertise,” said Charles Bendotti, senior vice president of people and culture. “We look forward to their contributions in accelerating business success and achieving our vision.”
The CCO will be Stefano Volpetti, an expert in marketing. The CLSO will be John O’Mullane, who will bring his expertise to developing new products beyond tobacco and nicotine. The role of CPO has been filled but has not been publicly announced.
